戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DYN 戴纳基

已收盘 05-17 16:00:00 EDT

27.68

-1.07

-3.72%

盘后28.05

+0.37+1.34%

19:43 EDT

最高28.37	最低27.04	成交量131.82万
今开28.30	昨收28.75	日振幅4.63%
总市值24.19亿	流通市值15.67亿	总股本8,738万
成交额3,652万	换手率2.33%	流通股本5,659万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DYN","market":"US","secType":"STK","nameCN":"戴纳基","latestPrice":27.68,"timestamp":1715976000000,"preClose":28.75,"halted":0,"volume":1318232,"hourTrading":{"tag":"盘后","latestPrice":28.05,"preClose":27.68,"latestTime":"19:43 EDT","volume":12626,"amount":349540.27,"timestamp":1715989405703},"delay":0,"floatShares":56594020,"shares":87382638,"eps":-3.908078,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.07,"latestTime":"05-17 16:00:00 EDT","open":28.3,"high":28.37,"low":27.04,"amount":36523795.279263996,"amplitude":0.046261,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.908078,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1600315200000,"adjPreClose":28.75,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":28.05,"preClose":27.68,"latestTime":"19:43 EDT","volume":12626,"amount":349540.27,"timestamp":1715989405703},"volumeRatio":1.539594},"requestUrl":"/m/hq/s/DYN","defaultTab":"news","newsList":[{"id":"2435549575","title":"戴纳基盘中异动 大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435549575","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435549575?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:22","pubTimestamp":1715707366,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日01时22分，戴纳基股票出现波动，股价快速拉升5.07%。截至发稿，该股报27.97美元/股，成交量25.5133万股，换手率0.29%，振幅5.32%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.19%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150122477927a2c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150122477927a2c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435797103","title":"戴纳基盘中异动 股价大涨5.69%报27.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435797103","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435797103?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:32","pubTimestamp":1715610720,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时32分，戴纳基股票出现波动，股价大幅上涨5.69%。截至发稿，该股报27.48美元/股，成交量22.0327万股，换手率0.25%，振幅3.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-65.65百万美元，每股收益-0.81美元，毛利-386000.00美元，市盈率-6.81倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为1.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132232007a599cc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132232007a599cc1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432131894","title":"HC Wainwright & Co.：重申Dyne Therapeutics(DYN.US)评级，由买入调整至买入评级, 目标价36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432131894","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432131894?lang=zh_cn&edition=full","pubTime":"2024-05-04 04:05","pubTimestamp":1714766712,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Dyne Therapeutics(DYN.US)评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040405178b71457d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040405178b71457d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432906293","title":"戴纳基盘中异动 股价大涨5.00%报27.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432906293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432906293?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:08","pubTimestamp":1714745287,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日22时08分，戴纳基股票出现异动，股价急速拉升5.00%。截至发稿，该股报27.30美元/股，成交量9.9631万股，换手率0.11%，振幅4.77%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.36%。该信息摘要如下：Dyne Therapeutics获大摩首次覆盖，给予增持评级, 目标价40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032208077925c1de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032208077925c1de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432635305","title":"戴纳基盘中异动 股价大涨5.18%报26.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432635305","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432635305?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:45","pubTimestamp":1714589100,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时45分，戴纳基股票出现波动，股价大幅拉升5.18%。截至发稿，该股报26.62美元/股，成交量32.323万股，换手率0.38%，振幅5.25%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为1.80%。该信息摘要如下：Dyne Therapeutics获大摩首次覆盖，给予增持评级, 目标价40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020245017a57df4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020245017a57df4f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431392900","title":"Dyne Therapeutics(DYN.US)获大摩首次覆盖，给予增持评级, 目标价40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431392900","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431392900?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:25","pubTimestamp":1714469116,"startTime":"0","endTime":"0","summary":"Dyne Therapeutics(DYN.US)获大摩首次覆盖，给予增持评级, 目标价40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301725188b65afdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301725188b65afdc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430528982","title":"戴纳基盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430528982","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430528982?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:42","pubTimestamp":1714052540,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时42分，戴纳基股票出现异动，股价大幅下跌5.08%。截至发稿，该股报23.71美元/股，成交量1.1253万股，换手率0.01%，振幅1.80%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为1.36%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521422087e83b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521422087e83b39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429276972","title":"戴纳基盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429276972","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429276972?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:48","pubTimestamp":1713808106,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日01时48分，戴纳基股票出现波动，股价急速拉升5.07%。截至发稿，该股报25.07美元/股，成交量30.9616万股，换手率0.36%，振幅6.12%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为1.89%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423014827861e7e46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423014827861e7e46&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427327417","title":"戴纳基盘中异动 大幅跳水5.15%报25.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427327417","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427327417?lang=zh_cn&edition=full","pubTime":"2024-04-13 00:16","pubTimestamp":1712938597,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日00时16分，戴纳基股票出现波动，股价急速跳水5.15%。截至发稿，该股报25.97美元/股，成交量15.0797万股，换手率0.17%，振幅5.44%。戴纳基股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Q32 Bio Inc.涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3485.75%、1374.67%、85.74%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、60.95%、58.59%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300163779203f1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300163779203f1a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425314204","title":"戴纳基盘中异动 急速跳水5.42%报27.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425314204","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425314204?lang=zh_cn&edition=full","pubTime":"2024-04-05 00:03","pubTimestamp":1712246590,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日00时03分，戴纳基股票出现异动，股价快速下跌5.42%。截至发稿，该股报27.20美元/股，成交量66.9656万股，换手率0.82%，振幅4.98%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.12%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040500031087e7e0db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040500031087e7e0db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424041833","title":"戴纳基盘中异动 大幅下跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424041833","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424041833?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:50","pubTimestamp":1712065810,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时50分，戴纳基股票出现异动，股价大幅下跌5.50%。截至发稿，该股报26.46美元/股，成交量5.6273万股，换手率0.07%，振幅1.27%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为1.41%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022150117a50b691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022150117a50b691&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422912412","title":"戴纳基盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422912412","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422912412?lang=zh_cn&edition=full","pubTime":"2024-03-27 23:49","pubTimestamp":1711554580,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日23时49分，戴纳基股票出现异动，股价急速拉升5.02%。截至发稿，该股报28.13美元/股，成交量116.603万股，换手率1.42%，振幅4.74%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.12%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327234940791d50a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327234940791d50a0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422144755","title":"BUZZ-戴恩公司任命新首席执行官后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2422144755","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422144755?lang=zh_cn&edition=full","pubTime":"2024-03-25 20:59","pubTimestamp":1711371588,"startTime":"0","endTime":"0","summary":"    3月25日 - ** Dyne Therapeutics   股价盘前下跌约11.5%至25美元** 该公司称  它将任命 John Cox 为新的首席执行官** Cox 将接替 Joshua Brumm，后者卸任后将担任 Dyne 的顾问 - DYNE** Dyne公司称，Cox曾担任过百健罕见病子公司Bioverativ的首席执行官，最近还担任过私营公司Repertoire Immune Medicines的首席执行官。** 这家肌肉疾病专家的股价在 1 月份翻了一番， ，此前该公司针对一种肌肉萎缩性疾病的实验性疗法在一项小型早期试验中显示出了前景。** 截至上次收盘，该公司股价在过去 12 个月里上涨了一倍多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2421407301","title":"戴纳基盘中异动 下午盘大幅拉升5.02%报29.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421407301","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421407301?lang=zh_cn&edition=full","pubTime":"2024-03-22 02:58","pubTimestamp":1711047484,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日02时58分，戴纳基股票出现异动，股价快速上涨5.02%。截至发稿，该股报29.31美元/股，成交量40.1911万股，换手率0.49%，振幅5.73%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.95%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032202580487e7acac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032202580487e7acac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420276923","title":"戴纳基盘中异动 早盘快速拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420276923","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420276923?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:57","pubTimestamp":1710860221,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时57分，戴纳基股票出现波动，股价快速上涨5.52%。截至发稿，该股报27.73美元/股，成交量12.4656万股，换手率0.15%，振幅5.71%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.15%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192257017a4db6fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192257017a4db6fc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420708794","title":"戴纳基盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420708794","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420708794?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:50","pubTimestamp":1710769823,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时50分，戴纳基股票出现波动，股价急速下挫5.00%。截至发稿，该股报26.59美元/股，成交量8.6644万股，换手率0.11%，振幅5.98%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.07%。戴纳基公司简介：Dyne Therapeutics Inc是一家生物技术公司，致力于为遗传疾病患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821502387e79c50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821502387e79c50&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419070939","title":"戴纳基盘中异动 股价大涨5.02%报28.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419070939","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419070939?lang=zh_cn&edition=full","pubTime":"2024-03-16 01:02","pubTimestamp":1710522148,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日01时02分，戴纳基股票出现波动，股价大幅拉升5.02%。截至发稿，该股报28.02美元/股，成交量39.834万股，换手率0.49%，振幅6.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.36亿美元，每股收益-3.95美元，毛利-2.46百万美元，市盈率-7.08倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031601022987e7965c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031601022987e7965c&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dyne-tx.com","stockEarnings":[{"period":"1week","weight":0.1079},{"period":"1month","weight":0.1673},{"period":"3month","weight":0.2549},{"period":"6month","weight":1.6089},{"period":"1year","weight":1.1186},{"period":"ytd","weight":1.1617}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dyne Therapeutics, Inc.于2017年12月1日根据特拉华州法律注册成立。该公司正在建立一家领先的肌肉疾病公司，致力于开发针对遗传驱动疾病患者的创新性改变生命的疗法。该公司正在利用其专有的FORCE平台来克服当前肌肉组织输送的局限性，并发展用于肌肉疾病的现代寡核苷酸疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.103315},{"month":2,"riseRate":0.5,"avgChangeRate":0.062424},{"month":3,"riseRate":0.5,"avgChangeRate":-0.021131},{"month":4,"riseRate":0.25,"avgChangeRate":-0.02854},{"month":5,"riseRate":0.5,"avgChangeRate":-0.008142},{"month":6,"riseRate":0.666667,"avgChangeRate":0.130887},{"month":7,"riseRate":0.666667,"avgChangeRate":0.156145},{"month":8,"riseRate":0,"avgChangeRate":-0.064301},{"month":9,"riseRate":0.333333,"avgChangeRate":0.013709},{"month":10,"riseRate":0.25,"avgChangeRate":-0.099447},{"month":11,"riseRate":0.5,"avgChangeRate":0.138032},{"month":12,"riseRate":0.5,"avgChangeRate":0.01734}],"exchange":"NASDAQ","name":"戴纳基","nameEN":"Dyne Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"戴纳基,DYN,戴纳基股票,戴纳基股票老虎,戴纳基股票老虎国际,戴纳基行情,戴纳基股票行情,戴纳基股价,戴纳基股市,戴纳基股票价格,戴纳基股票交易,戴纳基股票购买,戴纳基股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}